Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurofibroma | 3 | 2026 | 8 | 1.210 |
Why?
|
| Neurofibromatosis 1 | 3 | 2026 | 59 | 1.160 |
Why?
|
| Biological Specimen Banks | 2 | 2025 | 137 | 1.030 |
Why?
|
| Skin Neoplasms | 5 | 2026 | 865 | 0.920 |
Why?
|
| Family Characteristics | 2 | 2025 | 203 | 0.850 |
Why?
|
| Marriage | 1 | 2025 | 123 | 0.820 |
Why?
|
| Spouses | 1 | 2025 | 109 | 0.810 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2021 | 49 | 0.650 |
Why?
|
| Interleukin-6 | 2 | 2026 | 784 | 0.530 |
Why?
|
| Laser Therapy | 3 | 2025 | 146 | 0.520 |
Why?
|
| Dermatology | 3 | 2022 | 132 | 0.460 |
Why?
|
| United Kingdom | 3 | 2025 | 391 | 0.310 |
Why?
|
| Immune System Diseases | 1 | 2026 | 40 | 0.240 |
Why?
|
| Chromosomes | 1 | 2026 | 106 | 0.230 |
Why?
|
| Low-Level Light Therapy | 1 | 2025 | 7 | 0.220 |
Why?
|
| Infant, Low Birth Weight | 1 | 2025 | 156 | 0.210 |
Why?
|
| Vascular Malformations | 1 | 2025 | 53 | 0.210 |
Why?
|
| Face | 1 | 2025 | 176 | 0.200 |
Why?
|
| Sexual Partners | 1 | 2025 | 195 | 0.200 |
Why?
|
| Skin Diseases | 1 | 2025 | 152 | 0.190 |
Why?
|
| Pharmaceutical Preparations | 2 | 2022 | 172 | 0.190 |
Why?
|
| Ultrasonography | 2 | 2026 | 795 | 0.190 |
Why?
|
| Lasers | 2 | 2022 | 128 | 0.180 |
Why?
|
| Internship and Residency | 2 | 2022 | 1279 | 0.170 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2021 | 11 | 0.170 |
Why?
|
| Atherosclerosis | 1 | 2025 | 411 | 0.160 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 67 | 0.160 |
Why?
|
| Skin | 3 | 2026 | 759 | 0.160 |
Why?
|
| Genomics | 1 | 2026 | 839 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 708 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2025 | 722 | 0.150 |
Why?
|
| Genome-Wide Association Study | 2 | 2025 | 1496 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 663 | 0.140 |
Why?
|
| Smoking | 1 | 2025 | 1483 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2022 | 489 | 0.130 |
Why?
|
| Delphi Technique | 3 | 2025 | 347 | 0.130 |
Why?
|
| Isotretinoin | 1 | 2017 | 27 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 648 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2026 | 1188 | 0.130 |
Why?
|
| Humans | 19 | 2026 | 147293 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2018 | 245 | 0.120 |
Why?
|
| Dermatologic Agents | 1 | 2017 | 69 | 0.120 |
Why?
|
| Cicatrix | 1 | 2017 | 72 | 0.120 |
Why?
|
| Optics and Photonics | 1 | 2016 | 38 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2018 | 510 | 0.110 |
Why?
|
| Wound Healing | 1 | 2017 | 361 | 0.100 |
Why?
|
| Adult | 7 | 2026 | 41405 | 0.100 |
Why?
|
| Vaccines | 1 | 2018 | 389 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2026 | 2223 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2025 | 3022 | 0.090 |
Why?
|
| Depression | 1 | 2021 | 1599 | 0.080 |
Why?
|
| Consensus | 2 | 2025 | 476 | 0.080 |
Why?
|
| Aged | 3 | 2025 | 26514 | 0.080 |
Why?
|
| Middle Aged | 4 | 2025 | 36821 | 0.080 |
Why?
|
| Male | 6 | 2026 | 73950 | 0.070 |
Why?
|
| Female | 6 | 2026 | 80076 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2026 | 2458 | 0.060 |
Why?
|
| Scattering, Radiation | 1 | 2026 | 99 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2026 | 259 | 0.060 |
Why?
|
| Alopecia | 1 | 2025 | 37 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2026 | 512 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2026 | 254 | 0.050 |
Why?
|
| CpG Islands | 1 | 2025 | 176 | 0.050 |
Why?
|
| Haplotypes | 1 | 2026 | 509 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2026 | 430 | 0.050 |
Why?
|
| Pruritus | 1 | 2023 | 60 | 0.050 |
Why?
|
| Birth Weight | 1 | 2025 | 522 | 0.040 |
Why?
|
| Absorption, Physiological | 1 | 2021 | 5 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2022 | 153 | 0.040 |
Why?
|
| Animals | 2 | 2021 | 38410 | 0.040 |
Why?
|
| Patient Care | 1 | 2022 | 121 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2025 | 742 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 89 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 828 | 0.040 |
Why?
|
| Injections, Intradermal | 1 | 2018 | 13 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2021 | 385 | 0.040 |
Why?
|
| Adolescent | 3 | 2026 | 22825 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2022 | 914 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 217 | 0.030 |
Why?
|
| Algorithms | 1 | 2026 | 1868 | 0.030 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2017 | 25 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 776 | 0.030 |
Why?
|
| Young Adult | 2 | 2026 | 14437 | 0.030 |
Why?
|
| Curriculum | 1 | 2022 | 1082 | 0.030 |
Why?
|
| Mental Health | 1 | 2022 | 813 | 0.030 |
Why?
|
| Child | 2 | 2026 | 22979 | 0.030 |
Why?
|
| Biomarkers | 1 | 2026 | 4351 | 0.030 |
Why?
|
| Research Design | 1 | 2020 | 1157 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2025 | 6543 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 1912 | 0.020 |
Why?
|
| Pregnancy | 1 | 2025 | 7274 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 2434 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 11017 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 4169 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 3246 | 0.020 |
Why?
|
| Vaccination | 1 | 2018 | 1443 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 3009 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 6164 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 7173 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 18491 | 0.010 |
Why?
|